Researchers compared glycemic control in cohorts of severely obese adolescents with type 2 diabetes undergoing medical and surgical interventions.
Results comparing the prevalence of obesity amongst adolescents with the rate of bariatric surgeries were presented at ENDO 2018.
Roux-en Y gastric bypass increased the likelihood of nonvertebral fractures, including hip, wrist, and pelvic fractures.
A recent survey examines the correlation between bariatric surgery and rates of continuation, discontinuation, or initiation of antidiabetes treatment 6 years after bariatric surgery compared with a matched control obese group.
The Gram-negative bacterium Helicobacter pylori was associated with increased marginal ulceration rates, but otherwise had little impact on bariatric surgery outcomes.
A recent study reported that the risk for suicide and non-fatal self-harm was increased after bariatric surgery.
Bariatric surgery is associated with lower risks of obesity-related comorbidities but a clinically important increased risk for complications compared with medical treatment.
The rates of 3 major complications at less than 30 days after bariatric surgery are low and vary among surgical procedures.
Bariatric surgery appears to induce changes in the gastrointestinal tract and its interactions with the endocrine system in ways that may influence glycemic control.
Researchers examined how adipocyte size reduction and fatty acid metabolism contribute to remission in type 2 diabetes following bariatric surgery.
According to recent research published in JAMA Surgery, bariatric surgery at body mass index less than 40 kg/m² tends to achieve better results.
Further investigation is needed to examine the mechanism behind aspirin responsiveness following bariatric surgery.
Researchers followed 2218 patients from across the US who underwent bariatric surgery and were prescribed an opioid.
A significant interaction occurred between baseline glycemic status and treatment effect on microvascular disease incidence.
For obese patients with type 2 diabetes, bariatric surgery is associated with improved splanchnic vascular responses.
A patient notes concerns with vision difficulty 4 years after undergoing a laparoscopic biliopancreatic diversion with a duodenal switch.
There are fewer cases of incident diabetic retinopathy among obese patients with type 2 diabetes undergoing bariatric surgery compared with medical treatment.
Severely obese adolescents who underwent gastric bypass surgery experienced significant weight loss that was maintained over long-term follow-up.
Gastric bypass, but not gastric banding, is associated with reduced risk of psoriasis, progression to severe psoriasis, and psoriatic arthritis.
Although glucose control is initially superior following Roux-en-Y gastric bypass vs laparoscopic adjustable gastric banding, greater weight loss may attenuate this effect.
Bariatric surgery was associated with a significant reduction in risk of heart failure among obese patients.
Patients who undergo Roux-en-Y gastric bypass are less likely to die from obesity or other diseases than those who did not undergo the procedure 10 years later.
In a study of Swedish Obese Subjects participants, researchers found that bariatric surgery provided benefits above and beyond usual care for weight loss.
Women experienced weight loss as well as decreases in ovarian volume and markers of androgen excess.
Women with a history of bariatric surgery may have an increased risk of preterm birth.
Researchers reported improvements in hepatic insulin sensitivity, endogenous glucose production, and lipolysis.
A patient came to the clinic to discuss her dizzy spells 4 years after her Roux-en-Y gastric bypass surgery.
Much of the weight lost via bariatric surgery appears to stay off for at least 10 years, according to a study published online in JAMA Surgery.
Watch Christopher Thompson, MD, of Brigham and Women's Hospital, explain the minimally invasive endoscopic sleeve gastroplasty procedure for weight loss.
Pregnant women who have had bariatric surgery may have increased odds for premature delivery.
Endocrinology Advisor Articles
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Plasma Methylglyoxal Levels Associated With CVD, Mortality in Type 2 Diabetes
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- AMA: Federal Government Must Tackle Rising Insulin Prices
- Diabetes Medication Reconciliation May Reduce Risk of ED Visits